Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial

IMPORTANCE: The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of people worldwide. Tocilizumab has shown promising results in retrospective studies in patients with COVID-19 pneumonia with a good safety profile. OBJECTIVE: To evaluate the effect of early tocilizumab administra...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA Intern Med
Päätekijät: Salvarani, Carlo, Dolci, Giovanni, Massari, Marco, Merlo, Domenico Franco, Cavuto, Silvio, Savoldi, Luisa, Bruzzi, Paolo, Boni, Fabrizio, Braglia, Luca, Turrà, Caterina, Ballerini, Pier Ferruccio, Sciascia, Roberto, Zammarchi, Lorenzo, Para, Ombretta, Scotton, Pier Giorgio, Inojosa, Walter Omar, Ravagnani, Viviana, Salerno, Nicola Duccio, Sainaghi, Pier Paolo, Brignone, Alessandro, Codeluppi, Mauro, Teopompi, Elisabetta, Milesi, Maurizio, Bertomoro, Perla, Claudio, Norbiato, Salio, Mario, Falcone, Marco, Cenderello, Giovanni, Donghi, Lorenzo, Del Bono, Valerio, Colombelli, Paolo Luigi, Angheben, Andrea, Passaro, Angelina, Secondo, Giovanni, Pascale, Renato, Piazza, Ilaria, Facciolongo, Nicola, Costantini, Massimo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Medical Association 2021
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577199/
https://ncbi.nlm.nih.gov/pubmed/33080005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.6615
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia